Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vbi Vaccines Inc CS (NQ: VBIV )

0.8770 +0.0439 (+5.27%)
Streaming Delayed Price Updated: 12:37 PM EDT, Jul 7, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 552,724
Open 0.7841
Bid (Size) 0.8740 (3)
Ask (Size) 0.8800 (28)
Prev. Close 0.8331
Today's Range 0.7841 - 0.8890
52wk Range 0.6405 - 3.810
Shares Outstanding 258,257,494
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
VBI Vaccines Announces New Long-Term Follow-Up Clinical Data for its 3-Antigen Adult Hepatitis B Vaccine Presented at EASL 2022
From VBI Vaccines Inc.
Via Business Wire
The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga

Performance

YTD
-64.49%
-64.49%
1 Month
-1.46%
-1.46%
3 Month
-49.89%
-49.89%
6 Month
-59.95%
-59.95%
1 Year
-73.26%
-73.26%

More News

Read More
22 Stocks Moving in Thursday's Pre-Market Session
Via Benzinga
VBI Vaccines To Start Clinical Study Of Pan-Coronavirus Vaccine Candidate This Year
Via Benzinga
VBI Vaccines Announces Results of Annual General Meeting
From VBI Vaccines Inc.
Via Business Wire
VBI Vaccines Receives U.S. FDA Orphan Drug Designation for VBI-1901 for the Treatment of Glioblastoma
From VBI Vaccines Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
VBI Vaccines to Participate in the Jefferies Healthcare Conference
From VBI Vaccines Inc.
Via Business Wire
VBI Vaccines Presents Updated Phase 2a Tumor Response and Overall Survival Data for VBI-1901 in Recurrent GBM at the 2022 ASCO Annual Meeting
From VBI Vaccines Inc.
Via Business Wire
VBI Vaccines Announces UK MHRA Marketing Authorisation for PreHevbri™, a 3-Antigen Adult Hepatitis B Vaccine
From VBI Vaccines Inc.
Via Business Wire
VBI Vaccines Announces Abstract Accepted for Oral Presentation at EASL 2022
From VBI Vaccines Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
VBI Vaccines Presented Health Economics and Outcomes Research for PreHevbrio™ at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2022
From VBI Vaccines Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
VBI Vaccines Reports First Quarter 2022 Financial Results and Provides Corporate Update
From VBI Vaccines Inc.
Via Business Wire
VBI Vaccines Announces European Commission Marketing Authorisation for PreHevbri™, a 3-Antigen Adult Hepatitis B Vaccine
From VBI Vaccines Inc.
Via Business Wire
VBI Vaccines Announces Data from VBI-1901 in Recurrent Glioblastoma Patients Selected for Poster Discussion at the 2022 ASCO Annual Meeting
From VBI Vaccines Inc.
Via Business Wire
VBI Vaccines Announces New Data and Progress of VBI-2900, VBI’s eVLP Coronavirus Program
From VBI Vaccines Inc.
Via Business Wire
VBI Vaccines Announces PreHevbrio™ is Now Available in the United States for the Prevention of Hepatitis B in Adults
From VBI Vaccines Inc.
Via Business Wire
VBI Vaccines to Participate in the 32nd Annual Oppenheimer Healthcare Conference
From VBI Vaccines Inc.
Via Business Wire
VBI Vaccines Receives Positive CHMP Opinion for 3-Antigen Hepatitis B Vaccine for Immunization Against Hepatitis B Infection in Adults in the European Union
From VBI Vaccines Inc.
Via Business Wire
VBI Vaccines Announces PreHevbrio™ [Hepatitis B Vaccine (Recombinant)] Recommended by CDC Advisory Committee on Immunization Practices for the Prevention of Hepatitis B in Adults
From VBI Vaccines Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.